Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
1SMK
DownloadVisualize
BU of 1smk by Molmil
Mature and translocatable forms of glyoxysomal malate dehydrogenase have different activities and stabilities but similar crystal structures
Descriptor: CITRIC ACID, Malate dehydrogenase, glyoxysomal
Authors:Cox, B, Chit, M.M, Weaver, T, Bailey, J, Gietl, C, Bell, E, Banaszak, L.
Deposit date:2004-03-09
Release date:2005-01-25
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Organelle and translocatable forms of glyoxysomal malate dehydrogenase. The effect of the N-terminal presequence.
Febs J., 272, 2005
1MP1
DownloadVisualize
BU of 1mp1 by Molmil
Solution structure of the PWI motif from SRm160
Descriptor: Ser/Arg-related nuclear matrix protein
Authors:Szymczyna, B.R, Bowman, J, McCracken, S, Pineda-Lucena, A, Lu, Y, Cox, B, Lambermon, M, Graveley, B.R, Arrowsmith, C.H, Blencowe, B.J.
Deposit date:2002-09-11
Release date:2003-09-16
Last modified:2022-02-23
Method:SOLUTION NMR
Cite:Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing.
Genes Dev., 17, 2003
2HC1
DownloadVisualize
BU of 2hc1 by Molmil
Engineered catalytic domain of protein tyrosine phosphatase HPTPbeta.
Descriptor: ACETATE ION, CHLORIDE ION, Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M, Walter, R, Mekel, M.
Deposit date:2006-06-14
Release date:2006-06-27
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.3 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2HC2
DownloadVisualize
BU of 2hc2 by Molmil
Engineered protein tyrosine phosphatase beta catalytic domain
Descriptor: MAGNESIUM ION, Receptor-type tyrosine-protein phosphatase beta, SODIUM ION
Authors:Evdokimov, A.G, Pokross, M, Walter, R, Mekel, M.
Deposit date:2006-06-15
Release date:2006-06-27
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.4 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I4H
DownloadVisualize
BU of 2i4h by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain co-crystallized with a sulfamic acid inhibitor
Descriptor: CHLORIDE ION, MAGNESIUM ION, N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (2.15 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I3R
DownloadVisualize
BU of 2i3r by Molmil
Engineered catalytic domain of protein tyrosine phosphatase HPTPbeta
Descriptor: CHLORIDE ION, Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-20
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.85 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I3U
DownloadVisualize
BU of 2i3u by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors
Descriptor: Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-20
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.85 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I4E
DownloadVisualize
BU of 2i4e by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with inhibitors
Descriptor: Receptor-type tyrosine-protein phosphatase beta, VANADATE ION
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.75 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I4G
DownloadVisualize
BU of 2i4g by Molmil
Structural studies of protein tyrosine phosphatase beta catalytic domain in complex with a sulfamic acid (soaking experiment)
Descriptor: CHLORIDE ION, N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE, Receptor-type tyrosine-protein phosphatase beta
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M.
Deposit date:2006-08-21
Release date:2006-08-29
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.65 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006
2I5X
DownloadVisualize
BU of 2i5x by Molmil
Engineering the PTPbeta catalytic domain with improved crystallization properties
Descriptor: (4-ETHYLPHENYL)SULFAMIC ACID, CHLORIDE ION, MAGNESIUM ION, ...
Authors:Evdokimov, A.G, Pokross, M.E, Walter, R.L, Mekel, M, Klopfenstein, S.
Deposit date:2006-08-26
Release date:2006-09-05
Last modified:2023-08-30
Method:X-RAY DIFFRACTION (1.7 Å)
Cite:Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
Acta Crystallogr.,Sect.D, 62, 2006

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon